IL13 and arthritic joint disease: The mice were injected with anti-IL-4, IL-5 or IL-13 blocking monoclonal antibody (mAb) on day 3 before (−3d) and day 3 after (+3d) the second immunization with CII, and the incidence of arthritis was monitored.